Sign in
AXGN Stock Price, Chart, Stats & News
AxoGen, Inc.
Save
AxoGen, Inc. (AXGN) does not currently pay a dividend.
2.33B
Market cap
114.00x
Current P/E
105.26x
Forward P/E
AXGN chart
Fundamentals
Gross margin | 74.31% |
Operating margin | -3.49% |
Pretax margin | -6.97% |
Net margin | -6.97% |
Effective tax rate | – |
ROA | -7.08% |
ROE | -13.44% |
D/E | 0.15x |
Interest coverage ratio | -0.49x |
AXGN valuation
P/E | 114.00x |
P/S | 7.21x |
P/B | 11.39x |
P/CF | 1807.82x |
P/FCF | -495.23x |
P/OCF | 1807.82x |
PEG | 0.15x |
EV multiple | 185.82x |
About
AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves.
Similar securities
Based on sector and market capitalization
Report issue